BTBD8 activators constitute a specialized class of chemical compounds that have drawn attention in the field of molecular biology and genetics. These compounds are designed to modulate the activity of BTBD8, a protein-coding gene known to be involved in various cellular processes. BTBD8, which stands for Broad Complex, Tramtrack, and Bric-a-Brac (BTB) Domain-Containing Protein 8, is characterized by the presence of BTB domains, which are often associated with protein-protein interactions and regulation of gene expression. BTBD8 activators function by targeting specific regulatory elements within the BTBD8 gene, often situated in promoter or enhancer regions, with the primary goal of enhancing its transcription and subsequent translation into functional protein products.
The mechanisms through which BTBD8 activators exert their effects may vary, but their core purpose is to act as molecular switches, amplifying the activity of BTBD8. Researchers are continually exploring the potential applications and implications of BTBD8 activation, striving to deepen our understanding of how this gene contributes to cellular processes, particularly within the context of BTB domain-containing proteins and their roles in gene regulation and protein-protein interactions. This class of compounds holds promise for advancing our knowledge of gene regulation, specifically within the domain of BTB domain-containing proteins, offering insights into the intricate mechanisms that govern cellular processes and the role of BTBD8 in various biological contexts. BTBD8 activators serve as valuable tools in the ongoing exploration of molecular biology, providing opportunities to uncover the complex roles that BTBD8 plays in cellular functions and gene expression regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, may demethylate DNA, potentially leading to the activation of genes including BTBD8. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is an HDAC inhibitor, which can alter chromatin structure and enhance gene expression, possibly affecting BTBD8. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Disulfiram can modulate proteasome activity and may influence the expression of proteins involved in ubiquitination, such as BTBD8. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A binds to DNA and can inhibit transcription factor binding, potentially altering the expression of genes like BTBD8. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $75.00 $163.00 $622.00 $4906.00 $32140.00 | 43 | |
Sodium phenylbutyrate is an HDAC inhibitor that may cause changes in gene expression, which could include BTBD8. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid, another HDAC inhibitor, might modify gene expression profiles, thereby potentially influencing BTBD8 expression. | ||||||
Vitamin A | 68-26-8 | sc-280187 sc-280187A | 1 g 10 g | $377.00 $2602.00 | ||
Retinol acts as a ligand for nuclear receptors and can regulate gene transcription, possibly affecting BTBD8 expression. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $30.00 $115.00 $900.00 | 136 | |
DMSO is often used as a solvent but also can affect cellular processes and gene expression, hypothetically altering BTBD8 levels. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride influences the Wnt signaling pathway and may impact gene transcription, thus potentially affecting the expression of BTBD8. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
SAHA is an HDAC inhibitor that can open up chromatin for transcription, possibly leading to increased BTBD8 gene expression. | ||||||